Exposure to PD toxins (MPP+, rotenone) reproduces dopaminergic vulnerability within a 3D microenvironment, enabling evaluation of neuroprotective strategies targeting mitochondrial stabilization, oxidative stress reduction, or α-synuclein clearance. This evidence concerns the gene SNCA and Parkinson disease.